• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.

作者信息

Penton Rol G, Polentarutti N, Sironi M, Saccani S, Introna M, Mantovani A

机构信息

Department of Immunology and Cell Biology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

出版信息

Eur Cytokine Netw. 1997 Sep;8(3):265-9.

PMID:9346359
Abstract

Available information suggests that the type II IL-1 receptor (RII) is a nonsignaling molecule which acts as a decoy for IL-1. The decoy function model for RII was supported by gene transfer experiments in fibroblasts and keratinocytes. Therefore, inhibition of IL-1 responsiveness after decoy RII gene transfer could reflect a non-physiological cellular context and receptor number. In the present study, constructs encoding RII or a cytoplasmic deletion mutant (delta 372-398) were transfected into U937 cells which express only low levels of RI detectable by RT-PCR. Gene transfer resulted in receptor numbers (approximately equal to 10(3)/cell) of the same order of magnitude as that found in normal myelomonocytic cells. Transfer of RII or a cytoplasmic deletion mutant into U937 did not increase responsiveness to IL-1, as assessed by IL-8 expression and production; it actually considerably dampened it. These results are consistent with the view that in a myelomonocytic cellular context, RII does not contribute to signaling and represents a unique pathway of negative regulation of the IL-1 system.

摘要

相似文献

1
Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1.
Eur Cytokine Netw. 1997 Sep;8(3):265-9.
2
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.人单核吞噬细胞中白细胞介素-1诱饵受体的调控表达与释放
J Immunol. 1996 Apr 1;156(7):2534-41.
3
TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells.
J Immunol. 1997 Apr 15;158(8):3861-8.
4
Selectivity release of the type II decoy IL-1 receptor.II型诱饵白细胞介素-1受体的选择性释放
Cytokine. 2000 Jul;12(7):1001-6. doi: 10.1006/cyto.1999.0601.
5
The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.白细胞介素-1的II型诱饵受体可抑制小鼠胶原诱导的关节炎。
Eur J Immunol. 2000 Mar;30(3):867-75. doi: 10.1002/1521-4141(200003)30:3<867::AID-IMMU867>3.0.CO;2-M.
6
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.II型白细胞介素-1受体与白细胞介素-1受体辅助蛋白相互作用:白细胞介素-1反应性调节的新机制。
J Immunol. 1998 Dec 15;161(12):6871-7.
7
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.通过II型受体基因转移抑制白细胞介素-1反应性:一种具有抗白细胞介素-1功能的表面“受体”。
J Exp Med. 1996 Apr 1;183(4):1841-50. doi: 10.1084/jem.183.4.1841.
8
Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.转染的II型白细胞介素-1受体损害人角质形成细胞对白介素-1的反应性。
Am J Pathol. 1995 Dec;147(6):1852-61.
9
Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.将1型白细胞介素-1受体胞外域互补DNA导入兔滑膜细胞系HIG-82可导致白细胞介素-1信号转导的细胞阻断。
Arthritis Rheum. 1998 Mar;41(3):515-24. doi: 10.1002/1529-0131(199803)41:3<515::AID-ART18>3.0.CO;2-O.
10
Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.局灶性脑炎症中I型和II型白细胞介素-1受体的差异调节
Eur J Neurosci. 2005 Mar;21(5):1205-14. doi: 10.1111/j.1460-9568.2005.03965.x.

引用本文的文献

1
Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.采用 XOMA 052 进行途径衰减的动力学方法,XOMA 052 是一种调节白介素-1β活性的调节性治疗抗体。
J Biol Chem. 2010 Jul 2;285(27):20607-14. doi: 10.1074/jbc.M110.115790. Epub 2010 Apr 21.